483 Hangzhou Minsheng Binjiang Pharmaceutical Jul 2016

483 Hangzhou Minsheng Binjiang Pharmaceutical Jul 2016

$119 - Not in Stock

FDA investigators audited the Hangzhou Minsheng Binjiang Pharmaceutical - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 29 Jul 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jul 2016
  • Location: Hangzhou, China
  • FEI: 3007498452

Pre-Order Not Available